Clinical Trial Update: Aldosterone Antagonism in Diastolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating aldosterone antagonism for diastolic heart failure; the US Department of Veterans Affairs-sponsored study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Aldactone (spironolactone)
• Spironolactone (spironolactone)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Congestive Heart Failure, Diastole | Phase 4 | Status: COMPLETED